Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 20,581,313 $ 19,444,737
Accounts receivable 12,510 7,118
Prepaid expenses 598,367 303,178
Other current assets 786,642 576,660
Total Current Assets 21,978,832 20,331,693
Property and equipment, net 4,911,077 5,171,134
Operating lease right-of-use assets 383,551 326,085
Intangible assets, net 216,876 321,641
Total Assets 27,490,336 26,150,553
Current Liabilities    
Accounts payable 1,542,457 1,539,547
Accrued liabilities 3,841,013 3,491,740
Management and directors' fees payable 71,303 55,174
Current portion of long-term debt 797,855 841,319
Current portion of financing lease liabilities 48,958 59,930
Current portion of operating lease liabilities 171,166 179,624
Current portion of grant repayable 43,100 69,218
Total Current Liabilities 6,515,852 6,236,552
Long-term debt, net of current portion 2,270,767 2,606,885
Finance lease liabilities, net of current portion 511,086 601,967
Operating lease liabilities, net of current portion 217,305 151,828
Grant repayable, net of current portion 253,221 259,603
Total Liabilities 9,768,231 9,856,835
STOCKHOLDERS' EQUITY    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 53,223,761 shares and 48,607,017 shares, respectively 53,772 48,607
Additional paid-in capital 154,730,938 126,526,239
Accumulated other comprehensive income (loss) 148,326 (59,978)
Accumulated deficit (136,988,636) (110,173,971)
Total VolitionRx Limited Stockholders' Equity 17,944,400 16,340,897
Non-controlling interest (222,295) (47,179)
Total Stockholders' Equity 17,722,105 16,293,718
Total Liabilities and Stockholders' Equity $ 27,490,336 $ 26,150,553